Guangzhou Improve Med Instrument Total Liabilities
Guangzhou Improve Med Instrument total liabilities. Based on the latest financial reports, Guangzhou Improve Med Instrument (300030) has total liabilities worth CN¥346.01 Million CNY (≈ $50.63 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Guangzhou Improve Med Instrument's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Guangzhou Improve Med Instrument (2006–2025)
Total liabilities of Guangzhou Improve Med Instrument from 2006 to 2025. This chart illustrates how Guangzhou Improve Med Instrument's total liabilities have evolved over time, based on quarterly financial data. Explore Guangzhou Improve Med Instrument long-term investment allocation to see how much of total assets are deployed in long-term investments.
Guangzhou Improve Med Instrument Competitors by Total Liabilities
The table below lists competitors of Guangzhou Improve Med Instrument ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Tongda Power Technology Co Ltd
SHE:002576
|
China | CN¥729.83 Million |
|
Shifeng Cultural Development Co Ltd
SHE:002862
|
China | CN¥386.36 Million |
|
Zhejiang Dayang Biotech Group Co
SHE:003017
|
China | CN¥706.73 Million |
|
Sangam (India) Limited
NSE:SANGAMIND
|
India | Rs22.39 Billion |
|
Teqnion AB
ST:TEQ
|
Sweden | Skr1.31 Billion |
|
Ve Wong Corp
TW:1203
|
Taiwan | NT$3.36 Billion |
|
Shui On Land Limited
F:OL5
|
Germany | €43.40 Billion |
|
Hunan Creator Information Technologies Co Ltd Class A
SHE:300730
|
China | CN¥407.64 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Guangzhou Improve Med Instrument's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 300030 total assets.
Liquidity & Leverage Metrics
Guangzhou Improve Med Instrument Total Liabilities Ratios Explained
Guangzhou Improve Med Instrument total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangzhou Improve Med Instrument's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangzhou Improve Med Instrument (2006–2025)
The table below shows the annual total liabilities of Guangzhou Improve Med Instrument from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥371.82 Million ≈ $54.41 Million |
-38.06% |
| 2024-12-31 | CN¥600.28 Million ≈ $87.84 Million |
-9.55% |
| 2023-12-31 | CN¥663.63 Million ≈ $97.11 Million |
-10.03% |
| 2022-12-31 | CN¥737.57 Million ≈ $107.93 Million |
-7.18% |
| 2021-12-31 | CN¥794.63 Million ≈ $116.28 Million |
+7.10% |
| 2020-12-31 | CN¥741.94 Million ≈ $108.57 Million |
+10.98% |
| 2019-12-31 | CN¥668.54 Million ≈ $97.83 Million |
-3.90% |
| 2018-12-31 | CN¥695.67 Million ≈ $101.80 Million |
-11.06% |
| 2017-12-31 | CN¥782.15 Million ≈ $114.45 Million |
+51.67% |
| 2016-12-31 | CN¥515.70 Million ≈ $75.46 Million |
+1.34% |
| 2015-12-31 | CN¥508.88 Million ≈ $74.46 Million |
+114.42% |
| 2014-12-31 | CN¥237.33 Million ≈ $34.73 Million |
+115.02% |
| 2013-12-31 | CN¥110.38 Million ≈ $16.15 Million |
+40.42% |
| 2012-12-31 | CN¥78.60 Million ≈ $11.50 Million |
+14.80% |
| 2011-12-31 | CN¥68.47 Million ≈ $10.02 Million |
+16.66% |
| 2010-12-31 | CN¥58.69 Million ≈ $8.59 Million |
-37.77% |
| 2009-12-31 | CN¥94.31 Million ≈ $13.80 Million |
+49.80% |
| 2008-12-31 | CN¥62.96 Million ≈ $9.21 Million |
+303.20% |
| 2007-12-31 | CN¥15.61 Million ≈ $2.28 Million |
-24.27% |
| 2006-12-31 | CN¥20.62 Million ≈ $3.02 Million |
-- |
About Guangzhou Improve Med Instrument
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising feces and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company… Read more